34708-60-6

Basic information

• Product Name: 3-(3-HYDROXY-PHENYL)-PROPIONIC ACID ETHYL ESTER
• Synonyms: Benzenepropanoic acid, 3-hydroxy-, ethyl ester;3-(3-HYDROXY-PHENYL)-PROPIONIC ACID ETHYL ESTER;Ethyl 3-(m-hydroxyphenyl)propionate;Ethyl 3-(3-hydroxyphenyl)propanoate
• CAS NO: 34708-60-6
• Molecular Formula: C₁₁H₁₄O₃
• Molecular Weight: 194.23
• Mol File: 34708-60-6.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 309.699°C at 760 mmHg
• Flash Point: 129.476°C
• Appearance: /
• Density: 1.118g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.527
• PKA: 9.94±0.10(Predicted)
• CAS DataBase Reference: 3-(3-HYDROXY-PHENYL)-PROPIONIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3-HYDROXY-PHENYL)-PROPIONIC ACID ETHYL ESTER(34708-60-6)
• EPA Substance Registry System: 3-(3-HYDROXY-PHENYL)-PROPIONIC ACID ETHYL ESTER(34708-60-6)

Safety Data

• Hazardous Substances Data: 34708-60-6(Hazardous Substances Data)

Usage

General Description

3-(3-Hydroxy-phenyl)-propionic acid ethyl ester is a chemical compound with the molecular formula C11H14O3. It is a derivative of 3-hydroxyphenyl propionic acid and is commonly used in the pharmaceutical and fragrance industries. 3-(3-HYDROXY-PHENYL)-PROPIONIC ACID ETHYL ESTER has potential applications in the synthesis of various pharmaceutical drugs and as a scent ingredient in perfumes and personal care products. It is also known for its anti-inflammatory properties, making it an important compound in the development of drugs for the treatment of inflammatory conditions. 3-(3-Hydroxy-phenyl)-propionic acid ethyl ester is a versatile chemical with a wide range of potential uses and applications in various industries.

InChI:InChI=1/C11H14O3/c1-2-14-11(13)7-6-9-4-3-5-10(12)8-9/h3-5,8,12H,2,6-7H2,1H3

Upstream product

• 3943-96-2 3-(3-hydroxyphenyl)acrylic acid ethyl ester 
• 96251-92-2 (E)-3-(3-hydroxyphenyl)acrylic acid ethyl ester 
• 64-17-5 ethanol 
• 621-54-5 3-(3-hydroxyphenyl)-propanoic acid 
• 14755-02-3 3-hydroxy-trans-cinnamic acid 
• 14755-02-3 3-hydroxycinnamic acid 
• 4046-02-0 ethyl 4-hydroxy-3-methoxycinnamate 
• 591-20-8 3-Bromophenol 
• 140-88-5 ethyl acrylate 

Downstream Products

• 75849-10-4 ethyl 3-<3-(benzyloxy)phenyl>propanoate 
• 156005-68-4 3-{3-[3-(4-Acetyl-phenoxy)-propoxy]-phenyl}-propionic acid ethyl ester 
• 156005-47-9 3-<3-(allyloxy)phenyl>propionic acid ethyl ester 
• 156005-38-8 3-[3-(3-Bromo-propoxy)-phenyl]-propionic acid ethyl ester 
• 174813-74-2 ethyl 3-(3-butoxyphenyl)propanoate 
• 116609-01-9 3-(3-ethoxy-phenyl)-propionic acid ethyl ester 
• 1027377-50-9 3-(3-Isobutoxy-phenyl)-propionic acid ethyl ester 
• 156175-93-8 3-[3-(3-Fluoro-propoxy)-phenyl]-propionic acid ethyl ester 
• 1027051-93-9 3-[3-(4,4,4-Trifluoro-butoxy)-phenyl]-propionic acid ethyl ester 
• 156175-97-2 3-(3-sec-Butoxy-phenyl)-propionic acid ethyl ester 
• 156175-82-5 ethyl 3-(3-propoxyphenyl)propanoate 
• 174813-75-3 3-(3-Cyclopropylmethoxy-phenyl)-propionic acid ethyl ester 
• 494865-03-1 3-{3-[3,3-bis-(4-bromo-phenyl)-allyloxy]-phenyl}-propionic acid ethyl ester 
• 156175-83-6 1,2-dihydro-5-(3-propoxybenzyl)-2-thioxo-4(3H)-pyrimidinone 

Relevant articles and documents

Preparation method of aza compounds

The invention discloses a preparation method of aza compounds N-((5-(3-hydroxyphenyl)-2H-1,2,4-triazole-3-ol)methyl)-N-propyl-1-amine. 3-(3-hydroxyphenyl)ethyl acrylate serves as an initial material, a target product 7 is obtained through reduction, acyla

Benzocarbazoles dioxane derivatives, its preparation process and its use in medicine

The invention relates to a benzodioxane derivative, a preparation method thereof and application of the derivative in medicines. Specifically, the invention relates to a novel benzodioxane derivative shown as a formula (I), medial salt thereof or a medicine composition containing the derivative, and a preparation method of the derivative. The invention further relates to a use of the benzodioxane derivative and the medial salt thereof or the medicine composition containing the derivative in preparing therapeutic agent, especially GPR 40 agonist, and a drug for treating the diseases such as diabetes, metabolic disorders and the like, wherein each substituent group in the formula (I) is as defined in the description.

Calcilytic compounds

Novel calcilytic compounds and methods of using them are provided.